Source: International Congress 2014 – COPD exacerbations



Rating:

Share or cite this content

Citations should be made in the following way:
L. Marín Barrera, C. López Ramírez, J. L. López-Campos, C. Calero Acuña, A. Fernández-Villar, C. Represas Represas, C. Ramos Hernández, R. Casamor (Sevilla, Madrid, Vigo, Barcelona, Spain). Pharmacological treatment of COPD in the on-sint cohort. Eur Respir J 2014; 44: Suppl. 58, 536

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Evaluation of the use of CAT in COPD. Results of On-Sint study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Cardiovascular comorbidity in COPD: Tip of iceberg Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Is early diagnosis of COPD possible? Preliminary results of early COPD study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Factors influencing cognitive function in COPD Source: International Congress 2014 – The assessment of comorbidities Year: 2014 The German COPD cohort COSYCONET: Aims, methods and results of recruitment Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Surfactant protein expression at various COPD Gold stages Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Symptoms for anxiety and depression in COPD patients Source: International Congress 2014 – The assessment of comorbidities Year: 2014 What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014